IFNA1 and glioblastoma: MDMs and activated CD4+ T cells, both obtained from multiple donors, dividing and PMA-treated (differentiated) THP-1 and U937 cells, as well as U87-MG glioblastoma cells, were treated with 1000 U/ml IFNα for 24 h (for detailed description of experimental procedures, see Additional file 1).